Literature DB >> 25377725

Association between cervical screening and prevention of invasive cervical cancer in Ontario: a population-based case-control study.

Danielle Vicus1, Rinku Sutradhar, Yan Lu, Rachel Kupets, Lawrence Paszat.   

Abstract

OBJECTIVE: The aim of this study was to estimate the effect of cervical screening in the prevention of invasive cervical cancer among age groups, using a population-based case-control study in the province of Ontario, Canada.
METHODS: Exposure was defined as cervical cytology history greater than 3 months before the diagnosis date of cervical cancer (index date). Cases were women who were diagnosed with cervical cancer between January 1, 1998, and December 31, 2008. Controls were women without a diagnosis of cervical cancer on, or before, December 31, 2008. Two controls were matched to each case on year of birth and income quintile, as of the index date. Conditional logistic regression was used to estimate the odds ratio for having been screened among those with cervical cancer.
RESULTS: Cervical cancer screening performed between 3 and 36 months before the index date was protective against invasive cervical cancer in women aged 40 through 69 years. In women younger than 40 years, cervical cancer screening performed 3 to 36 months before the index date was not protective.
CONCLUSIONS: Cervical screening is associated with a reduced risk for invasive cervical cancer among women older than 40 years. Cervical cancer resources should be focused on maximizing the risk reduction.

Entities:  

Mesh:

Year:  2015        PMID: 25377725     DOI: 10.1097/IGC.0000000000000305

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

1.  Screening with Papanicolaou tests in Alberta: Are we Choosing Wisely?

Authors:  Christopher J Symonds; Wenxin Chen; Marianne Sarah Rose; Lara J Cooke
Journal:  Can Fam Physician       Date:  2018-01       Impact factor: 3.275

2.  Serum Immune Profiling for Early Detection of Cervical Disease.

Authors:  Radwa Ewaisha; Gitika Panicker; Paul Maranian; Elizabeth R Unger; Karen S Anderson
Journal:  Theranostics       Date:  2017-08-23       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.